World Multiple Sclerosis day, May 31, 2017

On the occasion of World Multiple Sclerosis day, on May 31st, the french magazine "Sciences et Avenir" dedicates an article to promising recent work from Catherine Lubetzki's team at the Brain and Spine Institute (ICM) in Paris.

Several studies from the team have shown the importance of the remyelination process in patient health state. In its most frequent form, multiple sclerosis is indeed charaterized by inflammatory bursts in the central nervous system (brain and spine), followed by respite periods during which myelin is partially rebuilt.

New imaging techniques developped at ICM, more precise than MRI, allowed to show that this reparation "potential" differs a lot among patients : by injecting a specific tracer that fixes on myelin, before performing a PET scan, the degree of myelin degradation can be measured.

You can find the complete article (in French) on the magazine website.

NEURATRIS at BIO-EUROPE SPRING 2017 (20th – 22nd March, Barcelona)

NeurATRIS is pleased to announce that we will be participating to Bio-Europe Spring (20th – 22nd March, Barcelona)

BIO-EUROPE SPRING is the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe's most innovative biopharma clusters.

This is a unique opportunity to learn more about NeurATRIS assets to work alongside in your translational projects in the Neuroscience field for the characterization of neurodegenerative diseases.

Do not hesitate to This email address is being protected from spambots. You need JavaScript enabled to view it. to set up a meeting.



Multiple sclerosis is an inflammatory disease of the nervous central system leading to a progressive destruction of the myelin sheath surrounding the axons, essential for their protection and for the transmission of the nerve impulse. Bruno Stankoff and Catherine Lubetzki’s team developed a cutting-edge imaging technique which makes possible to visualize neuron demyelination and remyelination and to quantify their degeneration. These results, published in Annals of Neurology, open the way to better treatment for patients and to the evaluation of novel remyelination therapies.



Thesis defense : “ Consequences of APP soluble forms overexpression in memory processes and its therapeutical application to Alzheimer’s disease.”

Wednesday September the 21st, World Alzheimer's Day, will be held at CEA of Fontenay aux roses a thesis defense by Romain Fol on this topic. The discussion will precisely focus on the “ Consequences of APP soluble forms overexpression in memory processes and its therapeutical application to Alzheimer’s disease.